US Supreme Court rejects blood monitoring patents 03/21/2012 majac Your Health Matters Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine. Share on FacebookTweetFollow usSave